Department of Neurosurgery, LMU University Hospital, LMU Munich, Marchioninistrasse 15, 81377, Munich, Germany.
German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.
Acta Neurochir (Wien). 2024 Apr 6;166(1):170. doi: 10.1007/s00701-024-06057-3.
Patients with intracranial meningiomas frequently suffer from tumor-related seizures prior to resection, impacting patients' quality of life. We aimed to elaborate on incidence and predictors for seizures in a patient cohort with meningiomas WHO grade 2 and 3.
We retrospectively searched for patients with meningioma WHO grade 2 and 3 according to the 2021 WHO classification undergoing tumor resection. Clinical, histopathological and imaging findings were collected and correlated with preoperative seizure development. Tumor and edema volumes were quantified.
Ninety-five patients with a mean age of 59.5 ± 16.0 years were included. Most tumors (86/95, 90.5%) were classified as atypical meningioma WHO grade 2. Nine of 95 tumors (9.5%) corresponded to anaplastic meningiomas WHO grade 3, including six patients harboring TERT promoter mutations. Meningiomas were most frequently located at the convexity in 38/95 patients (40.0%). Twenty-eight of 95 patients (29.5%) experienced preoperative seizures. Peritumoral edema was detected in 62/95 patients (65.3%) with a median volume of 9 cm (IR: 0-54 cm). Presence of peritumoral edema but not age, tumor localization, TERT promoter mutation, brain invasion or WHO grading was associated with incidence of preoperative seizures, as confirmed in multivariate analysis (OR: 6.61, 95% CI: 1.18, 58.12, p = *0.049). Postoperative freedom of seizures was achieved in 91/95 patients (95.8%).
Preoperative seizures were frequently encountered in about every third patient with meningioma WHO grade 2 or 3. Patients presenting with peritumoral edema on preoperative imaging are at particular risk for developing tumor-related seizures. Tumor resection was highly effective in achieving seizure freedom.
颅内脑膜瘤患者在切除前常伴有肿瘤相关性癫痫发作,这影响了患者的生活质量。我们旨在阐述世界卫生组织(WHO)2021 级脑膜瘤 2 级和 3 级患者中癫痫发作的发生率和预测因素。
我们按照 2021 年 WHO 分类标准,回顾性搜索了接受肿瘤切除术的脑膜瘤 WHO 2 级和 3 级患者。收集了临床、组织病理学和影像学发现,并与术前癫痫发作的发展相关联。对肿瘤和水肿体积进行了量化。
95 例患者的平均年龄为 59.5±16.0 岁。大多数肿瘤(86/95,90.5%)被归类为非典型脑膜瘤 WHO 2 级。9 例肿瘤(9.5%)为间变性脑膜瘤 WHO 3 级,包括 6 例存在 TERT 启动子突变的患者。95 例肿瘤中,38 例(40.0%)位于凸面最常见。95 例患者中有 28 例(29.5%)术前有癫痫发作。62 例患者(65.3%)存在瘤周水肿,中位数体积为 9cm(IR:0-54cm)。瘤周水肿的存在,但不是年龄、肿瘤定位、TERT 启动子突变、脑侵犯或 WHO 分级与术前癫痫发作的发生相关,这在多变量分析中得到了证实(OR:6.61,95%CI:1.18-58.12,p=*0.049)。95 例患者中有 91 例(95.8%)术后癫痫发作得到了控制。
约每 3 例 WHO 2 级或 3 级脑膜瘤患者中就有 1 例术前有癫痫发作。术前影像学检查存在瘤周水肿的患者发生肿瘤相关性癫痫发作的风险特别高。肿瘤切除术对控制癫痫发作非常有效。